Genomic Analysis of a Vaccinia Virus from a Patient with Vaccine Complications
Author Information
Author(s): Li Guiyun, Chen Nanhai, Feng Zehua, Buller R Mark L, Osborne John, Harms Tiara, Damon Inger, Upton Chris, Esteban David J
Primary Institution: University of Victoria
Hypothesis
Is the VACV-DUKE isolate from a patient with a smallpox vaccine-related complication genetically similar to other Dryvax isolates?
Conclusion
The VACV-DUKE isolate is genetically similar to other Dryvax isolates but has unique genomic features that may contribute to vaccine-related complications.
Supporting Evidence
- VACV-DUKE is the only Dryvax clone isolated from a patient with a vaccine-associated complication.
- The genomic sequence of VACV-DUKE is very similar to that of Dryvax cell culture-derived isolates.
- VACV-DUKE genome encodes 225 open reading frames, including 178 intact genes.
- Major genomic differences were found in specific genes compared to other Dryvax isolates.
Takeaway
This study looked at a virus from a patient who had problems after getting a smallpox vaccine and found that the virus is mostly like other vaccine viruses but has some special differences.
Methodology
The VACV-DUKE genome was sequenced using PCR amplification and standard DNA sequencing techniques.
Limitations
The immune status of the patient is unknown, and the study only analyzed a single lesion.
Participant Demographics
54-year-old female patient
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website